Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,774 | -24,590 | -14,346 | -10,256 | -47,221 |
| Depreciation Amortization | 117 | 211 | 81 | 139 | 591 |
| Accounts receivable | 300 | -300 | N/A | N/A | N/A |
| Other Working Capital | 92 | 1,718 | 673 | -679 | -522 |
| Other Operating Activity | 4,508 | 8,433 | 4,534 | 3,534 | 42,343 |
| Operating Cash Flow | $-15,757 | $-14,528 | $-9,058 | $-7,262 | $-4,809 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -174 | -2 | -239 | -26 |
| Investing Cash Flow | $N/A | $-174 | $-2 | $-239 | $-26 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 300 | N/A | N/A | N/A | N/A |
| Debt Repayment | -297 | -223 | -205 | -184 | -113 |
| Common Stock Issued | 4,008 | 17,647 | 16,722 | 9,900 | 280 |
| Other Financing Activity | 0 | 0 | 0 | 278 | 5,026 |
| Financing Cash Flow | $4,012 | $17,424 | $16,517 | $9,994 | $5,193 |
| Beginning Cash Position | 13,100 | 10,378 | 2,921 | 429 | 70 |
| End Cash Position | 1,355 | 13,100 | 10,378 | 2,921 | 429 |
| Net Cash Flow | $-11,745 | $2,722 | $7,457 | $2,493 | $359 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,757 | -14,528 | -9,058 | -7,262 | -4,809 |
| Capital Expenditure | N/A | -174 | -2 | -239 | -26 |
| Free Cash Flow | -15,757 | -14,702 | -9,060 | -7,501 | -4,835 |